# A rare case of liver regenerative and non-neoplastic lesion resembling a well-differentiated hepatocellular carcinoma

**Authors:** Kosuke Hirose, Takeo Toshima, Taro Tobo, Satohiro Kai, Masakazu Hirakawa, Satoshi Higuchi, Takashi Ofuchi, Kiyotaka Hosoda, Yusuke Yonemura, Yuichi Hisamatsu, Takaaki Masuda, Shinichi Aishima, Koshi Mimori

PMC · DOI: 10.1186/s40792-024-01820-1 · Surgical Case Reports · 2024-02-01

## TL;DR

A rare liver lesion resembling cancer was found to be non-cancerous regenerative changes, highlighting diagnostic challenges in liver diseases.

## Contribution

This case highlights a rare non-neoplastic liver lesion resembling hepatocellular carcinoma, emphasizing diagnostic difficulties in atypical hepatic nodules.

## Key findings

- The liver lesions were diagnosed as non-neoplastic regenerative changes with centrilobular necrosis.
- Preoperative imaging suggested malignancy, but histopathology ruled out neoplasia or hyperplasia.
- The case is classified as an NRH-like lesion, possibly linked to hepatic vessel disorder.

## Abstract

Nodular regenerative hyperplasia (NRH) is a rare disease that presents pathologically as diffuse hepatic nodules without fibrous septa. It is believed to be caused by vasculopathy against a background of various systemic diseases, such as hematologic, autoimmune, and drug-induced diseases, with various symptoms. In spite of the recent imaging advances, various atypical cases of nodular lesions are observed in daily clinical practice. Cases that do not completely meet these criteria are referred to as -like or -similar lesions in clinical situations, making it difficult to understand their pathogenesis. We present a case in which two hepatic nodular lesions were noted and difficult to differentiate from malignancy preoperatively. The lesions were laparoscopically resected and a pathological diagnosis with non-neoplastic liver regenerative nodules resembling NRH was made.

A 49-year-old man with no alcohol or drug intake and no past medical history was identified as having liver tumors on screening examination without any symptoms. Contrast-enhanced computed tomography (CT) showed two hepatic tumors; approximately 2-cm tumors at S7 and S8. Gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) revealed fat inclusions in their contents. Ethoxybenzyl (EOB) uptake was also observed during the hepatobiliary phase. Based on preoperative examinations, we suspected well-differentiated hepatocellular carcinoma (HCC) and performed laparoscopic S7/8 partial resection for these lesions. Macroscopically, the resected specimens showed a non-cirrhotic yellowish-cut surface containing brownish, ill-defined lesions with irregular borders. Microscopically, these lesions showed zonal necrosis, congestion, and aggregation of hemosiderin-laden macrophages around the central vein. In these areas, the fatty deposition of hepatocytes was lower than that in the surrounding background hepatocytes. Histopathologically, neither neoplastic nor hyperplastic lesions were observed, and he was diagnosed as regenerative hepatic change with centrilobular necrosis.

Considering the pathological results, these lesions were thought to be a type of NRH-like lesion with possible hepatic vessel disorder. However, the lesion’s cause and classification was difficult to determine. The accumulation of these regenerative changes accompanying fatty liver is needed to clarify the mechanism and its clinical significance.

## Linked entities

- **Chemicals:** Gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid (PubChem CID 91754427)
- **Diseases:** nodular regenerative hyperplasia (MONDO:0018835), hepatocellular carcinoma (MONDO:0007256)

## Full-text entities

- **Genes:** NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}
- **Diseases:** ascites (MESH:D001201), cirrhotic (MESH:D000094724), adenoma (MESH:D000236), colorectal liver metastases (MESH:D009362), microvascular disorder (MESH:D017566), systemic diseases (MESH:D034721), hyperplasia (MESH:D006965), hepatic virus infection (MESH:D006525), bleeding (MESH:D006470), thrombus (MESH:D013927), benign liver tumors (MESH:D017093), fatty deposits (MESH:D005234), heart failure (MESH:D006333), autoimmune (MESH:D001327), portal hypertension (MESH:D006975), MH (MESH:C535694), congestion (MESH:D002311), CT (MESH:C000719218), jaundice (MESH:D007565), vascular lesions (MESH:D014652), lesions (MESH:D009059), vasculopathy (MESH:D000090122), splenomegaly (MESH:D013163), varices (MESH:D014648), HCC (MESH:D006528), hematologic (MESH:D006402), hepatic vessel disorder (MESH:C536223), liver tumors (MESH:D008113), fatty (MESH:D008067), hepatic change (MESH:D056486), necrosis (MESH:D009336), rheumatoid arthritis (MESH:D001172), NRH (MESH:D020518), erythema (MESH:D004890), neoplastic lesions (MESH:D009062), atrophic (MESH:D020966), centrilobular necrosis (MESH:D011656), cirrhosis (MESH:D005355), hepatocyte atrophy (MESH:D001284), drug-induced diseases (MESH:D000081015), edema (MESH:D004487), gynecomastia (MESH:D006177), hepatic nodules (MESH:D016606), benign tumors (MESH:D009369), FLLs (MESH:D008107)
- **Chemicals:** eosin (MESH:D004801), hematoxylin (MESH:D006416), lipid (MESH:D008055), silver (MESH:D012834), alcohol (MESH:D000438), Gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid (MESH:C073590), EOB (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10834926/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10834926/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC10834926/full.md

---
Source: https://tomesphere.com/paper/PMC10834926